Kestra Advisory Services LLC Decreases Stake in BAT

Business by 2FIRSTS.ai
Dec.05.2023
Kestra Advisory Services LLC Decreases Stake in BAT
Kestra Advisory Services reduces its stake in British American Tobacco in Q2, according to recent SEC filings.

Kestra Advisory Services LLC reduced its stake in British American Tobacco p.l.c. by 1.6% in the second quarter.

 

According to the recent 13F filing submitted to the Securities and Exchange Commission (SEC), the company now holds a total of 47,162 shares of the company. This follows the sale of 758 shares during the quarter. As of the end of the recent quarter, Kest Consulting Services' investment value in British American Tobacco amounted to $1.566 million.

 

British American Tobacco is a global tobacco and nicotine product provider. They offer a range of products including e-cigarettes, tobacco heating, and modern oral nicotine products. They also provide cigarettes and traditional oral products such as Swedish-style snus and moist snuff. The company sells their products under various brands including Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555, and Shuangxi.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Tobacco Canada Seeks U.S. Recognition of $23.6 Billion Restructuring and Settlement Plan
Imperial Tobacco Canada Seeks U.S. Recognition of $23.6 Billion Restructuring and Settlement Plan
Tobacco giant Imperial Tobacco Canada seeks US court approval for $23.59 billion restructuring plan to settle lawsuits.
Aug.07 by 2FIRSTS.ai
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Caught between banning and not banning, the Russian government finds itself in a dilemma. The vape market generates substantial tax revenue, yet raises public health concerns. Lawmakers are applying pressure—some even suggest “following China”—as a regulatory storm quietly gathers.
Aug.22
Ukraine uncovers illegal disposable e-cigarette production case: 276,000 finished products seized, involving over $1.2 million
Ukraine uncovers illegal disposable e-cigarette production case: 276,000 finished products seized, involving over $1.2 million
The State Bureau of Economic Security of Ukraine (BEB) has uncovered a large-scale case involving the illegal production and sale of disposable e-cigarettes. This operation dismantled a massive underground production network, with the value of the involved goods reaching 50 million hryvnias (approximately 1.21 million US dollars). Law enforcement officers conducted more than 40 searches in Kyiv, Zhytomyr and other locations, seizing over 276,000 illegal e-cigarette products and related productio
Aug.08 by 2FIRSTS.ai
Experts to Debate Regional THR at first Asia Forum on Nicotine
Experts to Debate Regional THR at first Asia Forum on Nicotine
The first Asia Forum on Nicotine will be held on August 27, 2025, focusing on tobacco harm reduction in Asia. Experts will discuss regulation, scientific evidence, and clinical practice to promote cross-border dialogue and cooperation.
Aug.12
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. tobacco maker Cabbacis has secured a USPTO patent (No. 12,349,724) for oral vaporizer pods, effective until July 2038. With existing patents, its iBlend™ harm-reduction products—featuring low-nicotine and hemp blends—are now protected in over 30 countries and key global tobacco markets.
Jul.18 by 2FIRSTS.ai
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International’s U.S. affiliate (PMI America) has released a new white paper stating that U.S. healthcare professionals hold serious misconceptions about smoke-free products, with nearly half incorrectly believing that nicotine causes cancer. As a result, smokers are being denied scientifically accurate harm-reduction advice. The report calls on the U.S. Food and Drug Administration (FDA) to deliver accurate information on smoke-free alternatives to physicians, so they can help adul
Aug.19 by 2FIRSTS.ai